5-HT.sub.4 receptor antagonists
US5492919A · kind A · utility
13Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 1994 |
| Grant date | Feb 20, 1996 |
| Priority date | — |
| Expiry date | Jul 6, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides the use of a compound of formula (I) ##STR1## wherein A, E, F, U, X, Y, Z, are as defined in the specification, or a pharmaceutically acceptable salt thereof, for the treatment of diarrhea predominant irritable bowel syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.